Registration is a 2-step process!
Select 'ENROLL NOW' to register and gain access to the link that will allow you to complete part 2 of the 2-step registration process.
Thursday, June 25, 2020 (11:00AM - 12:30PM EDT)
*Pre-registration is required to participate.
In order for the immune system to effectively attack foreign cells, it relies on “checkpoints” — molecules on certain immune cells that activate (or inactivate) before initiating a response. Attend this session to hear experts in the field briefly review the immunology and pathways targeted by immune checkpoint inhibitors. They’ll also dive deep into related complications and present opportunities for community pharmacists to optimize care for patients receiving checkpoint inhibitor–based cancer therapy.
At the completion of this application-based activity, participants will be able to:
- State the mechanism of action of immune checkpoint inhibitors.
- Describe common symptoms associated with the use of immune checkpoint inhibitors.
- Discuss the appropriate steps a community pharmacist can take when encountering a patient receiving checkpoint inhibitor–based therapy who is exhibiting symptoms consistent with therapy complications.
Activity type: Application-based
Target Audience: Pharmacists
Learning Level: 1
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following webinar is approved for 1.5 contact hours of CPE credit (0.15 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-041-L01-P.
To obtain credit for completing Inhibitor-Based Cancer Therapy: How Community Pharmacists Can Optimize Care, participants will need to complete the 2-step registration process, attend the live webinar, complete the evaluation questions, and then CLAIM credit. An attendance code and detailed instructions on how to claim credit will be provided during the webinar. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: June 25, 2020
Expiration date to claim credit for LIVE webinar: August 24, 2020 (11:59PM EDT)
Development and Support
Inhibitor-Based Cancer Therapy: How Community Pharmacists Can Optimize Care is a live continuing education activity for pharmacists developed by the American Pharmacists Association. © 2020 American Pharmacists Association
This activity is supported by an independent educational grant from Merck Sharp and Dohme.
Tricia Schneider, PharmD, MBA; Daniel Zlott, PharmD, BCOP; and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
There is no fee associated with this activity. This learning product is a component of the APhA2020 Virtual Education package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
Inhibitor-Based Cancer Therapy
|Date||6/25/2020 11:00:00 AM|
|Address||2215 Constitution Ave, NW|
|City||Washington||State||District of Columbia||Zip Code||20037|